{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:30:57Z","timestamp":1715959857213},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.drugalcdep.2011.06.018","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T02:50:57Z","timestamp":1311475857000},"page":"224-228","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of the hydrolytic activity of a long-acting mutant bacterial cocaine in the presence of commonly co-administered drugs"],"prefix":"10.1016","volume":"119","author":[{"given":"Remy L.","family":"Brim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen R.","family":"Noon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diwahar","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger K.","family":"Sunahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0005","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/0002-9343(93)90212-8","article-title":"Influence of labetalol on cocaine-induced coronary vasoconstriction in humans","volume":"94","author":"Boehrer","year":"1993","journal-title":"Am. J. Med."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0010","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1128\/AEM.66.3.904-908.2000","article-title":"Gene cloning and nucleotide sequencing and properties of a cocaine esterase from Rhodococcus sp. strain MB1","volume":"66","author":"Bresler","year":"2000","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1124\/mol.109.060806","article-title":"A thermally stable form of bacterial cocaine esterase: a potential therapeutic agent for treatment of cocaine abuse","volume":"77","author":"Brim","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0020","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/sj.npp.1301666","article-title":"A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats","volume":"33","author":"Brimijoin","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0025","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/archinternmed.2010.397","article-title":"Identifying patients with cocaine-related chest pain at true risk for beta-blocker toxicity","volume":"170","author":"Canning","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0030","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/npp.2010.242","article-title":"Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase","volume":"36","author":"Collins","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2011.03.015","article-title":"Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats","author":"Collins","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0040","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1124\/mol.106.025999","article-title":"Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase","volume":"70","author":"Cooper","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0045","series-title":"Drug and Human Performance Fact Sheets","author":"Couper","year":"2004"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0376-8716(98)00098-2","article-title":"Serum time course of naltrexone and 6[beta]-naltrexol levels during long term treatment in drug addicts","volume":"52","author":"Ferrari","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0055","series-title":"Pharmacology and Abuse of Cocaine, Amphetamines, Ecstasy and Related Designer Drugs: A Comprehensive Review on their Mode of Action, Treatment of Abuse and Intoxication","author":"Freye","year":"2009"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0060","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/mol.108.049486","article-title":"Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity","volume":"75","author":"Gao","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0065","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1124\/jpet.104.068122","article-title":"An engineered cocaine hydrolase blunts and reverses cardiovascular responses to cocaine in rats","volume":"310","author":"Gao","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cbi.2008.04.024","article-title":"An albumin-butyrylcholinesterase for cocaine toxicity and addiction: catalytic and pharmacokinetic properties","volume":"175","author":"Gao","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0075","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/archinternmed.2010.398","article-title":"Beta-blockers and cocaine: still a bad idea","volume":"170","author":"Gupta","year":"2010","journal-title":"Arch. Intern. Med"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.annemergmed.2008.09.023","article-title":"A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality","volume":"54","author":"Jutkiewicz","year":"2009","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0085","series-title":"Karch's Pathology of Drug Abuse","author":"Karch","year":"2001"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0090","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1124\/jpet.106.114223","article-title":"Cocaine esterase: interactions with cocaine and immune responses in mice","volume":"320","author":"Ko","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nsb742","article-title":"Crystal structure of a bacterial cocaine esterase","volume":"9","author":"Larsen","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/taap.1997.8187","article-title":"Cocaine detoxification by human plasma butyrylcholinesterase","volume":"145","author":"Lynch","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/taap.1997.8188","article-title":"Therapeutic use of butyrylcholinesterase for cocaine intoxication","volume":"145","author":"Mattes","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0110","series-title":"Midazolam Hydrochloride [Package Insert] Lake Forest","year":"2004"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/protein\/gzq025","article-title":"Structural analysis of thermostabilizing mutations of cocaine esterase","volume":"23","author":"Narasimhan","year":"2010","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0120","series-title":"Narcan (R) [Package Insert]. Chadds Ford","year":"2003"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2007.06.007","article-title":"Blood naltrexone levels over time following naltrexone implant","volume":"32","author":"Ngo","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0130","doi-asserted-by":"crossref","first-page":"16656","DOI":"10.1073\/pnas.0507332102","article-title":"Computational redesign of human butyrylcholinesterase for anticocaine medication","volume":"102","author":"Pan","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0135","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archinternmed.2010.115","article-title":"Beta-blockers for chest pain associated with recent cocaine use","volume":"170","author":"Rangel","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0735-6757(91)90182-J","article-title":"Experience with esmolol for the treatment of cocaine-associated cardiovascular complications","volume":"9","author":"Sand","year":"1991","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0145","series-title":"Acute Cocaine Intoxication: Current Methods of Treatment","article-title":"Cocaine-related emergency department presentations","author":"Schrank","year":"1992"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0150","series-title":"Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings, Office of Applied Studies, NSDUH Series H-38A","author":"Substance Abuse and Mental Health Services Administration","year":"2010"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0155","doi-asserted-by":"crossref","first-page":"12297","DOI":"10.1021\/bi026131p","article-title":"Biochemical characterization and structural analysis of a highly proficient cocaine esterase","volume":"41","author":"Turner","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0160","series-title":"Office of Applied Studies. Drug Abuse Warning Network 2003: Interim National Estimates of Drug-Related Emergency Department Visits","author":"US Department of Health and Human Services","year":"2004"},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drugalcdep.2009.09.001","article-title":"Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats","volume":"106","author":"Wood","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2011.06.018_bib0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1124\/mol.110.068494","article-title":"Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine","volume":"79","author":"Xue","year":"2011","journal-title":"Mol. Pharmacol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871611002961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871611002961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T10:25:21Z","timestamp":1543659921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871611002961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0376871611002961"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.06.018","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}